Clinical characteristics affecting weight loss in an East Asian population receiving semaglutide: A STEP 6 subgroup analysis
Semaglutide reduces BW in a wide demographic of people with a range of weight-related comorbidities in an East Asian population.
Authors
- Soo Kyung Lim (ORCID: https://orcid.org/0000-0002-4137-1671)
- Toshimasa Yamauchi (ORCID: https://orcid.org/0000-0003-4827-6404)
- Sang Yeoup Lee (ORCID: https://orcid.org/0000-0002-3585-9910)
- Wataru Ogawa (ORCID: https://orcid.org/0000-0002-0432-4366)
- Takashi Kadowaki (ORCID: https://orcid.org/0000-0002-5428-3582)
- Maria Overvad (ORCID: https://orcid.org/0000-0002-4585-2042)
- Tomoyuki Nishida (ORCID: https://orcid.org/0009-0004-5812-7167)
- Kazuyuki Tobe (ORCID: https://orcid.org/0000-0003-0015-0255)
Institutions
- Novo Nordisk (Denmark) (DK)
- University of Toyama (JP)
- Kobe University (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Obesity Research & Clinical Practice
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1016/j.orcp.2025.01.002
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.43